FTC Demands Drug Divestment For $1.9B Mylan, Agila Merger
The Federal Trade Commission on Thursday said it will require Mylan Inc. and Agila Specialties Global Ltd. to divest 11 of their generic injectable drugs if they want to complete their...To view the full article, register now.
Already a subscriber? Click here to view full article